TIMBER PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Timber Pharmaceuticals, Inc. – TMBR

Posted by Business Wire August 29, 2023
timber-pharmaceuticals-investor-alert-by-the-former-attorney-general-of-louisiana:-kahn-swick-&-foti,-llc-investigates-timber-pharmaceuticals,-inc.-–-tmbr

NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Timber Pharmaceuticals, Inc. (“the Company”) (NYSE: TMBR) to LEO Pharma A/S. KSF is seeking to determine whether the transaction and the process that led to it are adequate and fair to the Company’s shareholders.


If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([email protected]) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nyse-tmbr/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC

Lewis S. Kahn

Managing Partner

[email protected]
855-768-1857

Business Wire
View More Posts

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

For the last half century, thousands of communications professionals have turned to us to deliver their news to the audiences most important to their business through the sources they trust most. Over that time, we've gone from a single office with one full time employee to more than 500 employees in 32 bureaus.